Literature DB >> 9518485

Additive antisense effects of different PNAs on the in vitro translation of the PML/RARalpha gene.

L Mologni1, P leCoutre, P E Nielsen, C Gambacorti-Passerini.   

Abstract

The potential use of peptide nucleic acid (PNA) as a sequence-specific inhibitor of RNA translation is investigated in this report. Three different regions of the PML/RARalpha oncogene, including two AUG potential start codons, were studied as targets of translation inhibition by antisense PNA in a cell-free system. A PNA targeted to the second AUG start codon, which was shown previously to be able to suppress in vitro translation from that site completely, was used alone or in combination with another PNA directed to the first AUG, and a third PNA within the 5'-untranslated region (5'-UTR) of mRNA. When used alone, no PNA was able to completely block the synthesis of the PML/RARalpha protein. The 5'-UTR PNA was the most potent translation inhibitor when used as single agent. However, a near complete (>/=90%) specific inhibition of the PML/RARalpha gene was obtained when the three PNAs were used in combination, thus obtaining an additive antisense effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518485      PMCID: PMC147505          DOI: 10.1093/nar/26.8.1934

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules.

Authors:  M Egholm; O Buchardt; L Christensen; C Behrens; S M Freier; D A Driver; R H Berg; S K Kim; B Norden; P E Nielsen
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

2.  Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.

Authors:  I Bongarzone; N Monzini; M G Borrello; C Carcano; G Ferraresi; E Arighi; P Mondellini; G Della Porta; M A Pierotti
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

3.  Single base pair mutation analysis by PNA directed PCR clamping.

Authors:  H Orum; P E Nielsen; M Egholm; R H Berg; O Buchardt; C Stanley
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

4.  Sequence specific inhibition of DNA restriction enzyme cleavage by PNA.

Authors:  P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

Review 5.  Acute promyelocytic leukemia: from genetics to treatment.

Authors:  F Grignani; M Fagioli; M Alcalay; L Longo; P P Pandolfi; E Donti; A Biondi; F Lo Coco; F Grignani; P G Pelicci
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

Review 6.  Gene inhibition using antisense oligodeoxynucleotides.

Authors:  R W Wagner
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

7.  Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand.

Authors:  P E Nielsen; M Egholm; O Buchardt
Journal:  Gene       Date:  1994-11-04       Impact factor: 3.688

8.  Inhibition of human telomerase activity by peptide nucleic acids.

Authors:  J C Norton; M A Piatyszek; W E Wright; J W Shay; D R Corey
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

9.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide.

Authors:  P E Nielsen; M Egholm; R H Berg; O Buchardt
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  6 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

Review 2.  The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.

Authors:  Franck Pellestor; Petra Paulasova
Journal:  Chromosoma       Date:  2004-05-19       Impact factor: 4.316

Review 3.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

4.  Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

Authors:  Jesse Deere; Pat Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.

Authors:  Bong-Seop Lee; Manabu Fujita; Natalya M Khazenzon; Kolja A Wawrowsky; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

6.  Identification of a long non-coding RNA regulator of liver carcinoma cell survival.

Authors:  Yulia Rybakova; John T Gonzalez; Roman Bogorad; Vikash P Chauhan; Yize L Dong; Charles A Whittaker; Timofei Zatsepin; Victor Koteliansky; Daniel G Anderson
Journal:  Cell Death Dis       Date:  2021-02-15       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.